■Daewoong Pharmaceutical announced on the 9th that it has unveiled clinical research data evaluating the treatment efficacy of Pecsuculu for patients with erosive esophagitis (EE) in India, as well as data on the preventive efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) against peptic ulcers at the Digestive Disease Week (DDW 2025) held in San Diego, USA, from the 3rd to the 6th. According to the company, results from a phase III study by an Indian partner showed that Pecsuculu demonstrated non-inferiority and significant symptom improvement in the treatment rate compared to the proton pump inhibitor (PPI) esomeprazole after 8 weeks. In the Clinical Global Impression-Improvement (CGI-I) evaluation scale, the proportion of patients rated as 'very much improved' or 'much improved' at the end of week 8 was 96.2% in the Pecsuculu group compared to 87.8% in the control group, indicating approximately a 1.1 times higher rate of symptom improvement with Pecsuculu.
■HK inno.N announced on the 9th that its slow-aging skincare brand "BeWants" has launched two new products. The products are the "Seaweed PDRN Glow Peel-Off Jelly Mask" and the "Deep Toning Glutathione Eye Serum Patch." According to the company, these two new products suggest focused care for clear and bright skin based on the beauty trend "glass skin." They will be available for purchase starting from the 12th on "Inno.N Mall" and the official Naver Smart Store "BeWants Mall," and on Amazon in the U.S. in June. The company plans to collaborate with global beauty influencers for concentrated entry into the global market.
■GC Biopharma announced on the 9th that it has signed a business memorandum of understanding with Chungbuk National University to promote a project for designating a global regional innovation leading research center. The project aims to establish a research center specialized in regional innovation and to consolidate basic research capabilities to create a sustainable innovation ecosystem that works in harmony with regional industries. Through this memorandum, GC Biopharma will conduct an industry-academia cooperation program with Chungbuk National University for the training of professionals in global regional innovation leading fields, including joint research and development and pharmacy.
■Dongkook Pharmaceutical announced on the 9th that it will launch two new products of its dermatocosmetic brand Centellian24, called the "Madeca Lab Glow Gel Mask," at Olive Young. The "Madeca Lab Glow Gel Mask" is designed to fit the skin perfectly, providing a refreshing cooling sensation and radiant glow from within. It consists of the "Hyaluronic Waterfull Glow Gel Mask" and the "PDRN Skin Tightening Glow Gel Mask." These products will be available for purchase online at Olive Young starting on the 14th and will be gradually available in major offline stores.
■HANDOK announced on the 9th that it will hold a customer appreciation event to commemorate the first anniversary of the launch of the continuous glucose monitoring device "BarojenFit." This event will take place from the 9th to the 15th of this month on the Naver brand store "HANDOK Mall," where 365 limited 10,000 won discount coupons for BarojenFit will be distributed. BarojenFit is a personal continuous glucose monitoring system launched in May last year, which can transmit blood glucose levels to a smartphone via Bluetooth every 5 minutes to check real-time levels and trends. In April, an upgraded product was introduced that significantly reduced sensor stabilization time to 30 minutes and changed fingertip blood sampling calibration from mandatory to optional.
■Dong-A Socio Group announced on the 9th that it will conduct the "Glorious 6.5km Walking Campaign" in collaboration with the Diabetes Research Foundation from the 1st to the 30th of this month. The 6.5km walking campaign aims to raise awareness of the importance of walking exercise for diabetics and to motivate consistent walking exercise. The distance of 6.5km is set to signify maintaining glycated hemoglobin below 6.5%, which is one of the diagnostic criteria for diabetes. To participate, individuals can download the walking donation mobile application "Walk on," select the 6.5km walking campaign, and donate steps collected in daily life. The funds raised through step donations will be used to support vulnerable groups of diabetics through the Diabetes Research Foundation.
■The Korea Bio Association announced on the 9th that it has signed a memorandum of understanding (MOU) with Biocom California to strengthen bio-industry cooperation between the two countries. Through this MOU, the two organizations plan to establish cooperative relationships between member corporations and advance mutual growth in areas such as innovation, investment, and market expansion. They will also pursue practical collaboration in various aspects, including technical and information exchanges, promoting joint investment and development, networking and joint issue identification between South Korean and U.S. companies, and hosting joint forums and networking events linking ongoing programs.